These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3042958)

  • 41. Bactericidal activity of cefotiam and ceftizoxime against Neisseria gonorrhoeae in an in vitro model simulating plasma and cantharidal blister fluid levels after the single intramuscular application of one gram.
    Korting HC; Niederauer H; Ollert M
    Chemotherapy; 1986; 32(3):260-9. PubMed ID: 3086050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative study of the effects of four cephalosporins against Escherichia coli in vitro and in vivo.
    van Ogtrop ML; Mattie H; Guiot HF; van Strijen E; Hazekamp-van Dokkum AM; van Furth R
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1932-7. PubMed ID: 2291658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum protein binding and extravascular diffusion of methoxyimino cephalosporins. Time courses of free and total concentrations of cefotaxime and ceftriaxone in serum and pleural exudate.
    Scaglione F; Raichi M; Fraschini F
    J Antimicrob Chemother; 1990 Sep; 26 Suppl A():1-10. PubMed ID: 2228838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High performance liquid chromatographic assay of cefsulodin, cefotiam and cefmenoxime in serum and urine.
    Itakura K; Mitani M; Aoki I; Usui Y
    Chem Pharm Bull (Tokyo); 1982 Feb; 30(2):622-7. PubMed ID: 6284390
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacokinetic study of cefodizime and ceftriaxone in sera and bones of patients undergoing hip arthroplasty.
    Scaglione F; De Martini G; Peretto L; Ghezzi R; Baratelli M; Arcidiacono MM; Fraschini F
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2292-4. PubMed ID: 9333066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antibiotic and specific immunoglobulin G in the treatment of E. coli sepsis in mice previously given steroids].
    Bakir M; Doğanay M; Dökmetaş I
    Mikrobiyol Bul; 1990 Oct; 24(4):336-43. PubMed ID: 2287291
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ceftriaxone versus cefotaxime in the treatment of septicemia in adults.
    Ferencz A; Prinz G; Szalka A; Ban E
    Chemotherapy; 1989; 35 Suppl 2():5-9. PubMed ID: 2612239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Intraocular penetration of systemically administered cephalosporins under steady-state conditions in animal experiments].
    Völker B; Mester U; Mendel N
    Ophthalmologica; 1985; 191(1):29-34. PubMed ID: 3861992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of side chains including the N-methyl-tetrazole-thiol group of beta-lactam antibiotics on transport in cultured kidney epithelial cells LLC-PK1.
    Goto K; Oda M; Saitoh H; Nishida M; Takada M
    Biol Pharm Bull; 1998 Oct; 21(10):1113-6. PubMed ID: 9821822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of cefotaxime and ceftriaxone on the bowel and vaginal flora after single-dose prophylaxis in vaginal hysterectomy.
    Bräutigam HH; Knothe H; Rangoonwala R
    Drugs; 1988; 35 Suppl 2():163-8. PubMed ID: 3135167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ceftriaxone diffusion into cardiac fibrin vegetation. Qualitative and quantitative evaluation by autoradiography.
    Crémieux AC; Mazière B; Vallois JM; Ottaviani M; Bouvet A; Pocidalo JJ; Carbon C
    Fundam Clin Pharmacol; 1991; 5(1):53-60. PubMed ID: 2066051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of protein binding on cefmenoxime steady-state kinetics in critical patients.
    Reitberg DP; Cumbo TJ; Smith IL; Schentag JJ
    Clin Pharmacol Ther; 1984 Jan; 35(1):64-73. PubMed ID: 6317272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pefloxacin in rabbits: protein binding, extravascular diffusion, urinary excretion and bactericidal effect in experimental endocarditis.
    Contrepois A; Daldoss C; Pangon B; Garaud JJ; Kecir M; Sarrazin C; Vallois JM; Carbon C
    J Antimicrob Chemother; 1984 Jul; 14(1):51-7. PubMed ID: 6384175
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role for dual individualization with cefmenoxime.
    Schentag JJ; Smith IL; Swanson DJ; DeAngelis C; Fracasso JE; Vari A; Vance JW
    Am J Med; 1984 Dec; 77(6A):43-50. PubMed ID: 6097124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The pharmacokinetics of ceftriaxone and cefotaxime in cirrhotic patients with ascites.
    Hary L; Andrejak M; Leleu S; Orfila J; Capron JP
    Eur J Clin Pharmacol; 1989; 36(6):613-6. PubMed ID: 2776819
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics and quantitative characterization of cefotiam excretion after intravenous administration to patients after cholecystectomy.
    Terziivanov D; Gerova Z; Vlahov V; Merdzhanov A; Damjanov D
    Eur J Clin Pharmacol; 1986; 30(4):439-44. PubMed ID: 3462003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic and kinetic properties of ceftazidime in animals.
    Acred P
    Infection; 1983; 11 Suppl 1():S44-8. PubMed ID: 6339418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of antibiotics in neonates.
    Sato Y
    Acta Paediatr Jpn; 1997 Feb; 39(1):124-31. PubMed ID: 9124044
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Concentrations of ceftriaxone in prostate adenoma tissue.
    Adam D; Naber KG
    Chemotherapy; 1984; 30(1):1-6. PubMed ID: 6198127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical pharmacokinetics and therapeutic efficacy of ceftriaxone in Chinese adults.
    Zhu Z; Wang AX; Li Y
    Chemotherapy; 1997; 43(3):218-26. PubMed ID: 9142464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.